Depression and incident HIV in adolescent girls and young women in HPTN 068:Targets for prevention and mediating factors by Goin, Dana E et al.
                          Goin, D. E., Pearson, R. M., Craske, M. G., Stein, A., Pettifor, A.,
Lippman, S. A., Kahn, K., Neilands, T. B., Hamilton, E. L., Selin, A.,
MacPhail, C., Wagner, R. G., Gomez-Olive, F. X., Twine, R., Hughes,
J. P., Agyei, Y., Laeyendecker, O., Tollman, S., & Ahern, J. (2019).
Depression and incident HIV in adolescent girls and young women in
HPTN 068: Targets for prevention and mediating factors. American
Journal of Epidemiology. https://doi.org/10.1093/aje/kwz238
Peer reviewed version
Link to published version (if available):
10.1093/aje/kwz238
Link to publication record in Explore Bristol Research
PDF-document
This is the author accepted manuscript (AAM). The final published version (version of record) is available online
via Oxford University Press at https://academic.oup.com/aje/advance-article/doi/10.1093/aje/kwz238/5609195 .
Please refer to any applicable terms of use of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the





Depression and incident HIV in adolescent girls and young women in HPTN 068: Targets for 
prevention and mediating factors 
 
Dana E. Goin, Rebecca M. Pearson, Michelle G. Craske, Alan Stein, Audrey Pettifor, Sheri A. 
Lippman, Kathleen Kahn, Torsten B. Neilands, Erica L. Hamilton, Amanda Selin, Catherine 
MacPhail, Ryan G. Wagner, F. Xavier Gomez-Olive, Rhian Twine, James P. Hughes, Yaw Agyei, 
Oliver Laeyendecker, Stephen Tollman, and Jennifer Ahern 
 
Correspondence to Dr. Jennifer Ahern, Division of Epidemiology & Biostatistics, School of Public 
Health, University of California, Berkeley, 2121 Berkeley Way West, Berkeley, CA 94720 (email: 
jahern@berkeley.edu) 
 
Editorial queries should be directed to Dr. Dana E. Goin, Division of Epidemiology & Biostatistics, 
School of Public Health, University of California, Berkeley, 2121 Berkeley Way West, Berkeley, CA 
94720 (email: degoin@berkeley.edu) 
 
Author affiliations: Division of Epidemiology & Biostatistics, School of Public Health, University of 
California, Berkeley, USA (Dana E. Goin, Jennifer Ahern); Centre for Academic Mental Health, 
Population Health Sciences, Bristol Medical School, Bristol University, Bristol, UK (Rebecca M. 
Pearson); National Institute for Health Research Bristol Biomedical Research Centre, Bristol, UK 
(Rebecca M. Pearson); Department of Psychology and Department of Psychiatry and Biobehavioral 
Sciences, University of California, Los Angeles, CA, USA (Michelle G. Craske); Medical Research 
Council/Wits University Rural Public Health and Health Transitions Research Unit (Agincourt), School 
of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South 
Africa (Alan Stein, Audrey Pettifor, Sheri A. Lippman, Kathleen Kahn, Amanda Selin, Catherine 
MacPhail, Ryan G. Wagner, F. Xavier Gomez-Olive, Rhian Twine, Stephen Tollman); Department of 
Psychiatry University of Oxford, Oxford, UK (Alan Stein); Department of Epidemiology, Gillings School 
of Global Public Health, University of North Carolina, Chapel Hill, USA (Audrey Pettifor); Wits 
Reproductive Health and HIV Institute, Faculty of Health Sciences, School of Clinical Medicine, 
University of the Witwatersrand, Johannesburg, South Africa (Audrey Pettifor, Catherine MacPhail); 
Department of Medicine, Division of Prevention Science, University of California, San Francisco, USA 
(Sheri A. Lippman, Torsten B. Neilands); HIV Prevention Trials Network (HPTN) Leadership and 
Operations Center, Science Facilitation Dept., FHI 360, Durham, NC, USA (Erica L. Hamilton); Carolina 
Population Center, University of North Carolina-Chapel Hill, Chapel Hill, NC, USA (Amanda Selin); 
School of Health and Society, University of Wollongong, NSW, Australia (Catherine MacPhail); 
Department of Biostatistics, School of Public Health, University of Washington, Seattle, WA, USA 
(James P. Hughes); Johns Hopkins University School of Medicine, Department of Pathology, 
Baltimore, MD, USA (Yaw Agyei); Laboratory of Immunoregulation, National Institute of Allergey and 
Infectious Diseases, National Institutes of Health, Bethesda, MD, USA (Oliver Laeyendecker); Division 
of Infectious Diseases, School of Medicine and Department of Epidemiology, School of Public Health, 
Johns Hopkins University, Baltimore, MD, USA (Oliver Laeyendecker). 
 
This study was funded by the National Institutes of Health (R01 MH110186) and by award numbers 
UM1 AI068619 (HPTN Leadership and Operations Center), UM1AI068617 (HPTN Statistical and Data 
Management Center), and UM1AI068613 (HPTN Laboratory Center) from the National Institute of 
Allergy and Infectious Diseases (NIAID), the National Institute of Mental Health (NIMH) and the 




supported by NIMH R01 (R01MH087118) and the Carolina Population Center and its NIH Center 
grant (P2C HD050924). Additional support was provided by the Division of Intramural Research, 
NIAID, NIH. The MRC/Wits Rural Public Health and Health Transitions Research Unit and Agincourt 
Health and Socio-Demographic Surveillance System, a node of the South African Population Research 
Infrastructure Network (SAPRIN), have been supported by the National Department of Science and 
Innovation, the University of the Witwatersrand, and the Medical Research Council, South Africa, 
and the Wellcome Trust, UK (grants 058893/Z/99/A; 069683/Z/02/Z; 
085477/Z/08/Z; 085477/B/08/Z). 
Conflict of interest: none declared.  








The human immunodeficiency virus (HIV) epidemic among adolescent girls and young women 
(AGYW) in sub-Saharan Africa is a critical public health problem. We assessed whether depressive 
symptoms in AGYW were longitudinally associated with incident HIV, and identified potential social 
and behavioral mediators. Data came from a randomized trial of a cash transfer conditional 
on school attendance among AGYW (ages 13 – 21) in rural Mpumalanga Province, South Africa 
during 2011-2017. We estimated the relationship between depressive symptoms and cumulative HIV 
incidence using a linear probability model, and assessed mediation using inverse odds ratio 
weighting. Inference was calculated using the non-parametric bootstrap. AGYW with depressive 
symptoms had higher cumulative incidence of HIV compared to those without (risk difference = 3.5 
[95% CI 0.1, 7.0]).  The strongest individual mediators of this association were parental monitoring 
and involvement (indirect effect = 1.6 [95% CI 0.0, 3.3]) and reporting a partner would hit her if she 
asked him to wear a condom (indirect effect = 1.5 [95% CI -0.3, 3.3]). All mediators jointly explained 
two-thirds (indirect effect = 2.4 [95% CI 0.2, 4.5]) of the association between depressive symptoms 










Every hour, 30 adolescents are infected with the human immunodeficiency virus (HIV) (1). In 
2016, the global number of adolescents aged 10-19 living with HIV rose to 2.1 million, a 30% increase 
since 2005 (1). Three in four new HIV infections among adolescents occur in sub-Saharan Africa (1), 
and adolescent girls are especially burdened. The ratio of adolescent girl to boy incident HIV 
infection in sub-Saharan Africa was almost 3:1 in 2017 (2). Understanding risk factors during 
adolescence before infection is thus crucial to inform prevention strategies. 
The most common method of HIV transmission worldwide, at almost 70% of infections, is 
unprotected heterosexual intercourse (3). Therefore, age at sexual debut, choice of partner, and 
risky sexual behavior are key targets for prevention (4). However, given limited success in reducing 
HIV incidence, there is increasing recognition of the critical need to address upstream factors that 
shape risky behaviors (5–8).  
Long standing evidence demonstrates a link between depression and HIV in sub-Saharan 
Africa (9,10). Depression is known to influence treatment adherence and mortality among HIV-
infected individuals (11,12). Furthermore, a high prevalence of depressive disorders has been 
reported at the time of HIV testing (13) and among HIV-infected individuals in South Africa (14–16). 
It is understood that a diagnosis of HIV can contribute to depression (17), given that it is a life-
threatening illness, requiring lifelong management and medication. The stigma of HIV likely 
contributes further to depression (18) and concerns about losing a job, a partnership or, in the case 
of pregnancy, the prospect of the infant acquiring HIV, add more stress (19).   
However, the possibility of depression as a risk factor for HIV incidence in sub-Saharan Africa 
has not been examined to date. Depressive symptoms have been linked to increased risk of HIV 
incidence among men who have sex with men in the United States (20,21), but the relationship has 
not previously been tested among adolescent girls and young women (AGYW) in sub-Saharan Africa, 




women are associated with increased alcohol use and risky sexual behaviors (22–25), both 
considered to be risk factors for HIV (3,26,27). The association between depression and risky sexual 
behaviors may be related to sexual abuse as child or sexual assault as an adolescent/adult (28). 
Furthermore, depression may lead to use of sex as a coping mechanism to regulate negative 
emotions, may increase a young woman’s attempt to please her partners (4,29), and may contribute 
to a lack of efficacy or power in sexual relationships (30–32). Depressive symptoms are also 
associated with reduced educational attainment (33), another known risk factor for HIV in this 
population (26,27,34), and limited involvement or engagement in community life (35). Finally, 
depression in adolescence can be associated with poor relationships with parents and can reduce 
parental closeness or involvement (36–38), which may in turn put girls at greater risk due to lower 
parental monitoring and advice.  
Existing evidence linking depression to risky sexual behavior and HIV infection in sub-Saharan 
Africa relies on cross sectional studies that leave the direction of causality unclear (i.e., is depression 
a cause or consequence of risky sexual behavior/HIV?) (9,10,14,17,39–41). In the current study, we 
utilised unique longitudinal data to test the hypothesis that depressive symptoms in early 
adolescence are associated with incident HIV infection. Furthermore, we investigated whether a 
range of social and behavioral factors mediated the relationship between depressive symptoms and 
incident HIV.  This study was conducted using the HIV Prevention Trials Network (HPTN) 068 cohort, 
a longitudinal study of AGYW in South Africa. We hypothesized that depressive symptoms in 
adolescence would increase HIV incidence, and this would be explained, at least in part, by 
behavioral mediators.  As depression is common and potentially modifiable in low and middle-






This cohort of AGYW was established in 2012 as part of an National Institutes of Health-
funded randomized controlled trial (HPTN 068) to estimate the effects of cash transfers conditional 
on school attendance on HIV incidence among adolescent girls in rural Mpumalanga Province, South 
Africa (26). Participants included 2,533 women in grades 8-11 (aged 13-21) at baseline. Eligibility 
criteria required the girls to be unmarried, not pregnant at enrolment, and to be able to read. They 
and their parent/guardian were also required to be able to open a bank account. All households with 
eligible AGYW in the study area were recruited; only 7% did not participate due to either 
parent/guardian or participant refusal (43).  The study did not exclude girls who tested positive for 
HIV infection at baseline in order to avoid undesired disclosure of HIV status. Additional details on 
the study recruitment and enrolment have been previously published (26,43). Participants were 
followed annually for up to four years, with additional graduation and post-intervention follow-up 
visits that resulted in follow-up duration of up to six years. Retention during the study period was 
approximately 91% (26). Participants completed detailed surveys about their economic and health 
behaviors, attitudes regarding social norms, and life experiences, and provided blood samples to test 
for HIV each year. Surveys about household composition and wealth were also undertaken with the 
participant’s head of household, providing rich longitudinal cohort data with HIV incidence at 
multiple time points throughout adolescence.  
Institutional Review Board approval for this study was obtained from the University of North 
Carolina at Chapel Hill, the University of the Witwatersrand Human Research Ethics Committee, and 
the Mpumalanga Province Health Research and Ethics Committee. Approval for analytic work was 
also obtained by the University of California, Berkeley, and the University of California, San Francisco.  
Exposure definition 
To assess depressive symptoms, we used a 10-item short form of the Children’s Depression 
Inventory scale (44) administered at the baseline visit. The reduced scale has comparable results 




validated in sub-Saharan Africa (48). Each question had three levels and, following standard practice, 
we coded the most positive response as 0, the middle response as 1, and the most negative response 
as 2. We summed the items over the 10 questions and we dichotomized the index at 7, which is the 
prorated equivalent of the recommended cut off at 19 from the full 27-item Children’s Depression 
Inventory, which is used to identify adolescents with depressive disorders in non-clinical samples 
(44,45). In a validation study of the short-form Children’s Depression Inventory in Rwanda, the 
sensitivity and specificity were 0.64 and 0.97, respectively, for the cut-off value of 7 (48).   
Outcome definition  
HIV status was determined at each follow-up visit by administering two parallel rapid HIV 
tests (the Determine HIV-1/2 test [Alere Medical Co, Matsudo-shi, Chiba, Japan] and the US Food 
and Drug Administration (FDA)-cleared Uni-gold Recombigen HIV test [Trinity Biotech, Bray, County 
Wicklow, Ireland]). If one or both tests were reactive or positive, confirmatory HIV testing was done 
with the FDA-cleared GS HIV-1 western blot assay (Bio-Rad Laboratories Inc, Redmond, WA, USA). A 
detailed description of study visit and laboratory procedures are published elsewhere (26).  
Cumulative incidence of HIV was evaluated from the second through the fifth follow-up visits, which 
spanned a period of up to six years. 
Mediator definitions 
We examined the following possible mediators, assessed at the first follow-up visit, which 
was approximately a year after the measurement of depressive symptoms. They included health and 
sexual behaviors, indicators of relationship power, and family or social involvement. Health and 
sexual behaviors included alcohol use more than once a month, number of partners in the past 12 
months, unprotected sex in the past 3 months, and purchased or received birth control or condoms 
in the past month. Indicators of relationship power included a recent sexual partner 5 years older, 
engaged in transactional sex in the past 12 months, a partner who would hit her if she asked him to 




would suspect she was cheating if she asked him to use a condom, low power according to the 
Sexual Relationship Power Scale (49), and intimate partner violence in the past 12 months. Family 
and social involvement mediators included having an average of > 5 days of missed school per month 
during the past year, attended > 80% of school days between follow-up visits, parental monitoring 
and involvement in girl’s life (a detailed description of this measure is provided in Web Appendix 1), 
and the number of community organizations of which the girl was a member.  
We chose these mediators based on literature that had identified these factors as behaviors 
that could be affected by depressive symptoms, may modify HIV risk, and could plausibly be targeted 
by interventions. 
Analytical Plan  
To establish temporal ordering between depressive symptoms, mediators and HIV, we 
excluded AGYW who were HIV infected at the baseline or first follow-up visit (n=113, 4.5%).  We 
considered mediators from the first annual follow-up visit to ensure temporality between depression 
at the baseline visit and mediators (Figure 1). HIV incidence was included from the second to the fifth 
annual follow-up visits, which spanned a period of up to six years.  
We controlled for baseline covariates that may have affected depressive symptoms, HIV 
incidence, and the mediators based on theory and prior literature. These included household food 
insecurity, per capita household consumption, percent of household members receiving a 
government grant, adverse and positive life events, orphan status, maternal and paternal 
educational attainment, pregnancy history, age, and trial arm. Detailed definitions of the covariates 
are available in Web Appendix 2.  
We estimated the effect of depressive symptoms on cumulative HIV incidence using a linear 
probability model to estimate parameters on the additive (risk difference) scale (50,51). For the 




weighting and considered multiple mediators (52,53). This method uses the invariance property of 
the odds ratio to create weights that block the association between depression and the mediator(s), 
thus isolating the natural direct effect of depression (i.e., the effect that does not go through the 
mediator(s)). Some strengths of this approach, in contrast to other available mediation methods 
(54,55), are that it allows multiple mediators to be considered simultaneously and allows for 
interactions between depression and the mediators. The natural indirect effect, the association of 
depression with HIV via the mediator(s), is the difference between the total effect and the natural 
direct effect. 
To account for covariate missingness we used multiple imputation with 30 imputed datasets 
(56). The non-parametric bootstrap was used to calculate 95% Wald-type confidence intervals (CI). 
We estimated direct and indirect effects for each mediator separately and all mediators jointly. We 
conducted a sensitivity analysis using inverse probability of censoring weights to assess whether loss 
to follow up affected our results. We also conducted a quantitative bias analysis using results on the 
risk ratio scale to assess how strong mediator-outcome confounding would need to be to change our 
results (57). A full description of this procedure is provided in Web Appendix 3.  
All analyses were performed using R version 3.4 (58). 
RESULTS 
Main effects 
There were 2,533 AGYW included in the study; of these, 118 were excluded as a result of 
having no information on HIV status (n=5, 0.2%) or were HIV positive at baseline or the first follow-
up visit (n=113, 4.5%). This resulted in a sample size of 2,415.  The prevalence of depressive 
symptoms and incidence of HIV varied across the baseline covariates (Table 1), but overall, 18.2% of 
AGYW were classified as having depressive symptoms at baseline, and the cumulative incidence of 




cumulative HIV incidence over the years of follow up, compared to 0.065 cumulative incidence 
among those without depressive symptoms (Table 2). After adjustment for covariates, depressive 
symptoms at baseline were associated with higher cumulative incidence of HIV (risk difference = 3.5 
[95% CI 0.1, 7.0)] (Table 3).  
Mediation 
Estimates of mediation parameters between depressive symptoms and HIV are presented in 
Table 3. The estimated natural direct effect on the risk difference scale of depressive symptoms on 
incident HIV considering all mediators jointly was 1.1 (-2.1, 4.4), while the estimated natural indirect 
effect considering all mediators was 2.4 (0.2, 4.5), suggesting that the mediators explain about two-
thirds of the absolute association between depressive symptoms and HIV when considered jointly. 
The remaining estimate of the natural direct effect suggests that depressive symptoms may also 
increase the risk of HIV through biological or other behavioral mechanisms not examined here.  
The mediators that individually explained the largest portion of the association between 
depressive symptoms and HIV incidence were parental monitoring and involvement and reporting 
that a partner would hit her if she asked him to wear a condom. The next strongest mediators were 
missing 5 or more days of school on average per month in the past year, having unprotected sex in 
the past 3 months, reporting her partner would assume she was cheating or become angry if she 
asked him to use a condom, and experiencing intimate partner violence in the past 12 months. 
Having a partner 5 or more years older, engaging in transactional sex, and the number of community 
organizations AGYW were involved with mediated the smallest portions of the overall association. 
The results did not meaningfully change when we used inverse probability of censoring weights to 
control for differential loss to follow up (Web Table 1).  
 We conducted a quantitative bias analysis on the risk ratio scale for the amount of 




mediation analysis that considered all mediators jointly (Web Table 2). We found that unobserved 
confounding would need to be strong in order to alter our findings (Web Tables 3 and 4).  
DISCUSSION 
This study examined the association of depressive symptoms with HIV incidence among 
AGYW in South Africa, a population bearing a large burden of HIV/AIDS and the highest number of 
incident cases in the region hardest hit by the epidemic. We found prevalence of depressive 
symptoms of 18.2% in this young adolescent population, which was almost twice the prevalence 
recorded in a nationally-representative survey of adults in South Africa (59). Previous evidence in 
sub-Saharan Africa showed that HIV infection increased risk of depression (15,18,40), and depression 
reduced treatment adherence and survival among HIV positive individuals (10,11,41). Cross-sectional 
studies also suggested a co-occurrence of depression and HIV (14,39). The findings of this study 
suggest that having depressive symptoms in adolescence may also increase risk of HIV infection. To 
our knowledge, this is the first demonstration that depression is longitudinally related to HIV 
acquisition among AGYW in sub-Saharan Africa. The results are especially important given the high 
burden of depression among adolescents and point to areas for prevention strategies.  
Because depression has been linked to lower condom use (30), and unprotected sex is the 
main route of HIV transmission in South Africa (60), we considered mediators that might connect 
depressive symptoms to behaviors that could influence risk of HIV.  Mediators considered in this 
study, including alcohol use, school attendance, parental monitoring and involvement, community 
participation, sexual behaviors, and sexual relationship power, jointly explained about two-thirds of 
this association. Parental monitoring and involvement and reporting fear that a partner would hit 
her if she requested he use a condom were responsible for the largest estimated individual 
mediation effects. However, we acknowledge that these mediators represent complex behaviors 
whose development may have preceded and contributed to the manifestation of depressive 




complicated emotional and social factors over time, but by measuring them at distinct visits we 
attempted to capture meaningful temporal connections between them and their relationships to HIV 
incidence.  
Evidence indicates that parental monitoring and involvement can influence HIV risk. Parental 
involvement has been linked to reduced sexual activity and risky sexual behavior among adolescents 
in sub-Saharan Africa (61,62), and parental communication around sexuality and sexual risk-taking 
with adolescent children has been tied to improved self-efficacy and interpersonal communication 
about sex, especially among AGYW (36). Positive parenting has been identified as an important 
contributor to adolescent physical and mental health in sub-Saharan Africa (63–65), but the 
directional relationship between parental involvement and child mental health and behavior is less 
well-studied. However, evidence from the United States indicates that the relationship between 
parental monitoring and child behavior is bi-directional (37) and that the direction of the relationship 
changes as children age into adolescence (38). For example, increased parental monitoring has been 
associated with lower childhood depression (66), but during adolescence, child behavior can also 
affect parental monitoring and parenting behaviors (38). Our results suggest that lack of parental 
monitoring and involvement plays an important role in mediating the association of adolescent 
depressive symptoms with HIV incidence, such that depression leads to less involvement from 
parents, which then increases risk of HIV. However, it is also possible that parental monitoring and 
involvement earlier in a child’s life influences later parental behavior, in addition to depressive 
symptoms and risky sexual behaviors.    
Having gender-based power imbalances in sexual relationships has been tied to increased 
risk of acquiring HIV and other STIs in South Africa (67,68), and has also been associated with 
inconsistent condom use (31). Previous work has shown South African men who were physically 
violent toward a partner were more likely to be HIV positive, increasing HIV risk for those partners 




increased risk of depression in sub-Saharan Africa (32), and the results of this study indicate that 
AGYW with depressive symptoms may be more vulnerable to relationships in which they have less 
power or control over decision making. One of the largest estimated mediation effects was observed 
for AGYW reporting a partner would hit her if she requested he use a condom. Having a partner who 
would assume infidelity or become angry if she requested he use a condom during sex and 
experiencing intimate partner violence in the past 12 months also had some of the largest estimated 
mediation effects. These results indicate that depressive symptoms may reduce the ability of AGYW 
to negotiate condom use during sex and increase their risk of HIV. Depression may also be associated 
with choosing sexual partners who are less open to negotiation or who are more likely to commit 
intimate partner violence.  
In South Africa, children’s mental health has been linked to school attendance and other 
educational outcomes (70). Furthermore, remaining in school and educational attainment during 
adolescence are protective against for HIV incidence among AGYW in South Africa (34). School 
attendance was inversely related to both depressive symptoms and HIV incidence in this cohort, and 
missing more than 5 days of school on average per month was among the largest estimated 
individual mediation effects.  
There were some limitations to this work. Although we were able to control for a large set of 
social, economic, and demographic covariates, residual confounding is always a concern in 
observational studies. Our total effect estimates assume there is no unmeasured confounding 
between the exposure and outcome. Additional assumptions for causal inference are positivity, 
consistency, and the stable unit treatment value assumption. Furthermore, our measurements of 
depressive symptoms and social and behavioral factors were self-reported. This could introduce 
same-source bias, in which measurement error is correlated because, for example, depressive 
symptoms could affect a young woman’s perception of parental monitoring or recall of past 




outcome, as HIV status was determined by blood test. In addition, while our sample included a large 
cohort of AGYW, we nonetheless had limited power to detect natural direct and indirect effects, 
particularly for a rare outcome. Detection of mediation effects tend to be underpowered with 
sample sizes designed for main effects only (71). Furthermore, when estimating natural direct and 
natural indirect effects there are several assumptions that need to be considered beyond those in a 
total effect analysis. In particular, in addition to concern about confounding between the exposure 
and outcome, there must also be no confounding of the exposure and the mediator, and the 
mediator and the outcome. We conducted a quantitative bias analysis to assess how strong 
unmeasured mediator-outcome confounding would need to be to invalidate our results and found 
strong confounding would be necessary, increasing our confidence in the findings.  
Our results suggest that interventions that improve mental health among AGYW may also 
improve HIV prevention efforts. They suggest the importance of incorporating family support and 
educational or empowerment initiatives around condom use, negotiating condom use with respect 
to gender-based sexual relationship power, and addressing male norms around condom use in 
prevention programming. While depression is a modifiable public health problem, access to mental 
healthcare services in South Africa is currently quite poor. Nevertheless, relatively low-cost 
interventions, delivered by lay workers in the community, have been shown to be effective in low- 
and middle-income countries, such as the rural South African context (72–74). Such interventions in 
adolescence, targeting depression as well as parental relationships and addressing social and 
structural factors that encourage women to participate in sexual relationships with gender-based 
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Table 1. Descriptive statistics for baseline covariates, severe depressive symptoms, and HIV 
incidence for the HPTN 068 cohort during 2011-2017, Mpumalanga, South Africa 
 Covariates N  
Depressive 
Symptoms (%) 
HIV positive  
(%)   
Orphaning statusa       
 Single orphan (1 parent deceased) 567 19.5 8.1 
 Double orphan (2 parents deceased)  105 20.8 10.2 
Household economic status       
 Food insecureb   
   
  No 2,022 17.9 7.7 
  Yes 393 19.5 10.1 
 Total household per capita expenditure 
decilesb 
     
  1 242 16.4 9.6 
  2 235 17.0 8.6 
  3 240 21.5 7.6 
  4 244 15.5 6.6 
  5 246 20.9 7.3 
  6 242 19.0 8.8 
  7 241 20.7 12.6 
  8 239 17.4 8.4 
  9 240 18.0 7.6 
  10 246 15.4 3.7 
 More than 25% of household receiving a 
government grantb 
     
  No 560 14.8 7.0 
  Yes 1,855 19.2 8.4 
 Maternal educationc   
   
  No school 443 18.7 8.0 
  Some primary 480 21.8 9.4 
  Completed primary 111 23.0 7.1 
  Some high school 716 17.9 9.9 
  Completed high school 570 16.0 5.6 
  University or technikon 94 7.1 3.0 
 Paternal education   
   
  No school 499 17.9 9.4 
  Some primary 433 21.3 9.2 
  Completed primary 125 20.7 8.5 
  Some high school 553 17.6 8.4 
  Completed high school 687 17.3 7.0 




 Any negative life eventb   
   
  No 1,772 17.8 8.2 
  Yes 643 19.3 7.8 
 Any positive life eventb   
   
  No 1,965 18.4 7.8 
  Yes   450 17.1 9.3 
Demographics       
 Ever been pregnant   
   
  No 2,211 16.6 7.5 
  Yes 204 35.4 15.0 
 Age at baseline   
   
  13 269 15.2 6.3 
  14 482 13.5 5.5 
  15 527 18.1 7.5 
  16 505 16.1 8.7 
  17 358 18.6 10.0 
  18 163 34.7 11.4 
  19 79 31.4 11.9 
  20+ 32 28.2 19.2 
Trial arm        
 Control 1212 17.3 8.3 
 Intervention 1203 19.1 7.9 
 
HTPN is the HIV Prevention Trials Network, HIV is the Human Immunodeficiency Virus. 
a This category does not sum to the total because it does not include participants for whom both parents are 
still living.  
b Details on measurement and definitions of these variables are available in Web Appendix 2. 





Table 2. HIV incidence by exposure status and year of follow-up for the HPTN 068 cohort from 2011-2017, Mpumalanga, South Africa 




































2 22 2329 0.009 0.009 16 1906 0.008 0.008 6 423 0.014 0.014 
3 43 2136 0.020 0.027 27 1747 0.015 0.022 16 389 0.041 0.050 
4 42 1913 0.022 0.044 34 1570 0.022 0.039 8 343 0.023 0.068 
5 36 1336 0.027 0.059 26 1093 0.024 0.052 10 243 0.041 0.091 
6 32 671 0.048 0.072 25 547 0.046 0.065 7 124 0.056 0.107 
Total  175 8385 0.021 0.072 128 6863 0.019 0.065 47 1522 0.031 0.107 
 
HTPN is the HIV Prevention Trials Network, HIV is the Human Immunodeficiency Virus. 
a The total observed person-years at risk at the second year of follow-up is N=2329 rather than the total N=2415 because 86 were lost to follow-up before 
the second year.  




 Table 3. Estimated total effects of depressive symptoms on HIV incidence and estimated natural direct and indirect effects with several mediators in the 




95% CI  
Natural indirect 
effect 
95% CI  
Health and school behaviors         
Alcohol use in the past month 2.40 -1.0, 5.8 1.10  -0.4, 2.7 
More than 5 days of missed school on average per month in the past year 2.10 -1.3, 5.4 1.40  -0.2, 3.1 
High school attendance between rounds (>80%) 2.30 -1.1, 5.7 1.20   -0.4, 2.8 
Parental monitoring and involvement 1.90 -1.3, 5.0 1.60    0.0, 3.3 
Community engagement (number of community organizations involved in) 2.60 -0.9, 6.1 0.90   -0.7, 2.5 
Sexual behaviors and self-efficacy         
Had a recent sexual partner 5 years or more older than oneself 2.50 -0.9, 5.9 1.00  -0.5, 2.6 
Number of partners in the past 12 months (0, 1, 2 or more) 2.30 -1.1, 5.7 1.20   -0.4, 2.9 
Had unprotected sex in the past 3 months 2.20 -1.2, 5.5 1.40   -0.3, 3.0 
Engaged in transactional sex in the past 12 months 2.50 -1.0, 6.0 1.00  -0.6, 2.6 
Sexual relationship power: partner would hit me if I requested he use a condom 2.00 -1.3, 5.2 1.50   -0.3, 3.3 
Sexual relationship power: partner would be angry if I requested he use a condom 2.20 -1.1, 5.6 1.30   -0.4, 3.0 
Sexual relationship power: partner would assume I'm cheating if I ask him to use a condom 2.20 -1.2, 5.5 1.40  -0.3, 3.0 
Low power according to sexual relationship power scale  2.30 -1.0, 5.6 1.20  -0.4, 2.9 
Experienced intimate partner violence in the past 12 months  2.20 -1.1, 5.5 1.30   -0.3, 2.8  
Purchased birth control or condoms 2.40 -1.0, 5.7 1.20  -0.4, 2.7 
All mediators 1.10 -2.1, 4.4 2.40   0.2, 4.5 
 
HTPN is the HIV Prevention Trials Network, HIV is the Human Immunodeficiency Virus, CI is confidence interval. 
The estimated total effect risk difference and 95% confidence interval was 3.5 (0.1, 7.0).  
Estimates are adjusted for household consumption, food insecurity, any negative or positive events, the percent of the household receiving a government grant, orphaning 




Figure 1. Timeline of depressive symptoms measurement, mediator assessment, and HIV testing 
over the course of the study. 
